Analysis

KB Home’s Q3 results expected to benefit from built-to-order model, stable demand

KB Home (NYSE: KBH) has been resilient to challenges like high mortgage rates and the inflation-induced strain on family budgets, while benefitting

Earnings Preview: FedEx’s Q1 results likely to reflect organizational restructuring

FedEx Corporation (NYSE: FDX) is on the path to a major transformation, with its organizational structure undergoing sweeping changes to become a

Ulta Beauty (ULTA): Near-term challenges faced by the beauty retailer and its expectations for the year

Shares of Ulta Beauty, Inc. (NASDAQ: ULTA) stayed red on Wednesday. The stock has dropped over 4% in the past three months.

Interviews

AlphaStreet's dedicated Earnings Call section is your one-source destination for all publicly listed earnings conference calls. Listen to CEOs/CFOs discuss their company's earnings reports while Wall Street Analysts ask (or grill) with their hard hitting questions.

Most Read

KB Home’s Q3 results expected to benefit from built-to-order model, stable demand

KB Home (NYSE: KBH) has been resilient to challenges like high mortgage rates and the inflation-induced strain on family budgets, while benefitting from the recovery in the housing market. When

September 13, 2024

Signet Jewelers (SIG) reports lower Q2 2025 sales and adj. profit

Signet Jewelers Limited (NYSE: SIG) has reported a decline in net sales and adjusted earnings for the second quarter of 2025. Same-store sales declined 3.4% during the three months. Net

September 13, 2024

Adobe reports higher Q3 revenue and earnings; results beat estimates

Design software maker Adobe Inc. (NASDAQ: ADBE) on Thursday reported an increase in third-quarter 2024 revenue and earnings. The results also topped expectations. Third-quarter revenues came in at $5.41 billion,

September 12, 2024

Research Summary

SentinelOne, Inc. (NYSE: S) Research Summary

SentinelOne, Inc. (NYSE: S) is a leading cybersecurity company that offers advanced threat protection

Ocean Biomedical (NASDAQ: OCEA) Research Summary

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a preclinical biotech company focused on moving new

Viewing Highlight
Loading...
Highlight
Close
Top